RPRX · Forms 3, 4, 5
Insider trades at Royalty Pharma plc
2 insiders sold $6.3M of Royalty Pharma plc stock on the open market in the last 30 days.
Every Form 3, 4 and 5 filed for Royalty Pharma plc (RPRX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Marshall Urist | EVP, Research & Investments | Sell | 4,126 | $57.10 | $236K | Form 4 | |
| Bonnie L Bassler | Director | Award | 642 | $58.41 | $37K | Form 4 | |
| Marshall Urist | EVP, Research & Investments | Sell | 4,126 | $57.88 | $239K | Form 4 | |
| Christopher Hite | EVP & Chairman, Partnering | Sell | 96,073 | $58.51 | $5.6M | Form 4 | |
| Christopher Hite | EVP & Chairman, Partnering | Sell | 3,927 | $58.93 | $231K | Form 4 | |
| Christopher Hite | EVP & Chairman, Partnering | Gift | 16,800 | Form 4 | |||
| Christopher Hite | EVP & Chairman, Partnering | Sell | 100,000 | $59.97 | $6M | Form 4 | |
| Terrance P. Coyne | EVP & CFO | Sell | 9,230 | $58.59 | $541K | Form 4 | |
| Terrance P. Coyne | EVP & CFO | Sell | 1,772 | $59.14 | $105K | Form 4 | |
| Pablo G. Legorreta | CEO, Chairman of the Board | Award | 65,216 | Form 4 | |||
| Terrance P. Coyne | EVP & CFO | Award | 11,002 | Form 4 | |||
| Christopher Hite | EVP & Chairman, Partnering | Award | 11,002 | Form 4 | |||
| Marshall Urist | EVP, Research & Investments | Award | 8,252 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.